NSC |
Compound |
Enrichment |
Correlation |
NSC 736780 |
(2Z,4E)-2-cyano-5-[4-(diethylamino)phenyl]penta-2,4-dienethi oamide |
0.00910228844192553 |
0.33064832 |
NSC 743874 |
Null |
0.00910228844192553 |
0.41582027 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.0091022884419256 |
0.35906507 |
NSC 133118 |
2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) |
0.0091022884419256 |
0.048469739 |
NSC 135073 |
WITHACNISTIN |
0.0091022884419256 |
0.64622729 |
NSC 144163 |
Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- |
0.0091022884419256 |
0.60799849 |
NSC 276361 |
1H-Pyrrole-3,4-dimethanol, 1-(4-butylphenyl)-2,5-dimethyl-, bis(methylcarbamate) (ester) |
0.0091022884419256 |
0.12640725 |
NSC 603084 |
2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (E)- |
0.0091022884419256 |
0.61269199 |
NSC 618770 |
Piperidin-4-ol, N-ethyl-N-methyl-3-(1-oxo-3-phenyl-2-propen-1-yl)-4-(2-phenylethen-1-yl)-, (E,E)-, bromide |
0.0091022884419256 |
0.51050562 |
NSC 623166 |
Null |
0.0091022884419256 |
0.43923753 |